BIXT
Bioxytran Inc

251
Loading...
Loading...
BioXyTran, Inc. engages in the development, manufacture, and commercialization of therapeutic drugs designed to address hypoxia in humans, which is a lack of oxygen in tissues. Its product pipeline includes BXT-25, a drug designed to oxygenate ischemic (reduced blood flow) regions in the brain that suffered from hypoxia during a brain stroke, and BXT-252, which treats chronic wounds resulting from ischemia caused by occlusion of capillaries. The company was founded on June 9, 2008 and is headquartered in Needham, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
3

Frequently Asked Questions

What is Market Cap of Bioxytran Inc?
What is the 52-week high for Bioxytran Inc?
What is the 52-week low for Bioxytran Inc?
What is Bioxytran Inc stock price today?
What was Bioxytran Inc stock price yesterday?
What is the PE ratio of Bioxytran Inc?
What is the Price-to-Book ratio of Bioxytran Inc?
What is the 50-day moving average of Bioxytran Inc?
How many employess does Bioxytran Inc has?

Latest BIXT News

View

Advertisement. Remove ads.

Advertisement. Remove ads.